Issue Navigation
-
Review
-
105-111
Urolithins and intestinal health
Lu CH, Li XT, Gao ZY, Song YL, Shen YM
Drug Discov Ther. 2022; 16(3):105-111.
DOI: 10.5582/ddt.2022.01039
-
112-117
Potential applications of Chinese herbal medicines with hemostatic properties
Ohkura N
Drug Discov Ther. 2022; 16(3):112-117.
DOI: 10.5582/ddt.2022.01037
-
118-123
Aoike M, Mori Y, Hotta K, Shigeno Y, Aoyama Y, Tanaka M, Kozai H, Kawamura H, Tsurudome M, Ito M
Drug Discov Ther. 2022; 16(3):118-123.
DOI: 10.5582/ddt.2022.01041
-
124-127
Izumo T, Awano N, Kuse N, Sakamoto K, Takada K, Muto Y, Fujimoto K, Saiki A, Ito Y, Ota H, Inomata M
Drug Discov Ther. 2022; 16(3):124-127.
DOI: 10.5582/ddt.2022.01036
-
128-134
Murayama R, Oyama H, Abe-Doi M, Masamoto Y, Kashiwabara K, Tobe H, Komiyama C, Sanada H, Kurokawa M
Drug Discov Ther. 2022; 16(3):128-134.
DOI: 10.5582/ddt.2022.01034
-
135-138
Proposal of an in vitro thrombus-growth model for evaluating anticoagulants
Sawaguchi Y, Yamamoto H, Itou S, Tachibana K, Ohnuma K, Kamada Y, Nakajima T
Drug Discov Ther. 2022; 16(3):135-138.
DOI: 10.5582/ddt.2022.01040
-
139-141
Chen GB, Lu HZ
Drug Discov Ther. 2022; 16(3):139-141.
DOI: 10.5582/ddt.2022.01032
-
142-144
Kobayashi S, Tagawa S, Ogura T, Kitaoka A, Yasu T
Drug Discov Ther. 2022; 16(3):142-144.
DOI: 10.5582/ddt.2022.01038
-
145-147
Neuroleptic malignant syndrome in a case of extra-pontine myelinolysis: On the horns of dilemma
Arora U, Goel A, Ray A, Vikram NK
Drug Discov Ther. 2022; 16(3):145-147.
DOI: 10.5582/ddt.2021.01012